PT Suparma Tbk (IDX:SPMA)

ShockWave Medical Income Statement

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	2,742,202	2,729,636	2,658,521	3,138,054	2,794,453	2,151,495
Revenue Growth (YoY)	4.17%	2.67%	-15.28%	12.30%	29.88%	-14.42%
Cost of Revenue	2,360,131	2,324,167	2,196,750	2,427,849	2,212,061	1,765,848
Gross Profit	382,071	405,469	461,771	710,205	582,392	385,647
Selling, General & Admin	221,059	209,905	206,708	183,723	169,709	154,023
Other Operating Expenses	5,654	5,228	-	613.51	-	2,560
Operating Expenses	226,713	215,133	206,708	184,337	169,709	156,583
Operating Income	155,358	190,336	255,063	525,868	412,683	229,064
Interest Expense	-33,285	-35,208	-34,876	-32,682	-31,355	-33,558
Interest & Investment Income	6,723	7,541	5,809	4,247	1,344	2,783
Currency Exchange Gain (Loss)	12,514	-29,452	9,086	-65,997	335.94	-2,217
Other Non Operating Income (Expenses)	-4,297	-3,424	3,042	632.25	3,373	-568.22
EBT Excluding Unusual Items	137,013	129,793	238,124	432,068	386,381	195,503
Gain (Loss) on Sale of Investments	1,450	4,650	-461.94	-622.47	-	-
Gain (Loss) on Sale of Assets	-	-	186.72	-	-	-
Other Unusual Items	-	-	-	-	-8,871	-
Pretax Income	139,705	134,443	237,849	431,446	377,510	195,503
Income Tax Expense	30,812	29,604	59,190	95,308	83,184	32,979
Net Income	108,893	104,839	178,658	336,138	294,326	162,525
Net Income to Common	108,893	104,839	178,658	336,138	294,326	162,525
Net Income Growth	0.58%	-41.32%	-46.85%	14.21%	81.10%	24.06%
Shares Outstanding (Basic)	3,154	3,154	3,154	3,154	3,154	3,154
Shares Outstanding (Diluted)	3,154	3,154	3,154	3,154	3,154	3,154
EPS (Basic)	34.52	33.24	56.64	106.57	93.32	51.53
EPS (Diluted)	34.52	33.24	56.64	106.57	93.32	51.53
EPS Growth	0.58%	-41.32%	-46.85%	14.21%	81.10%	24.06%
Free Cash Flow	587,828	671,488	654,950	862,153	744,770	640,090
Free Cash Flow Per Share	186.37	212.89	207.65	273.34	236.13	202.94
Dividend Per Share	-	-	12.000	-	-	10.056
Gross Margin	13.93%	14.85%	17.37%	22.63%	20.84%	17.93%
Operating Margin	5.67%	6.97%	9.59%	16.76%	14.77%	10.65%
Profit Margin	3.97%	3.84%	6.72%	10.71%	10.53%	7.55%
Free Cash Flow Margin	21.44%	24.60%	24.64%	27.47%	26.65%	29.75%
EBITDA	269,487	299,377	352,014	616,613	493,098	322,469
EBITDA Margin	9.83%	10.97%	13.24%	19.65%	17.65%	14.99%
D&A For EBITDA	114,129	109,041	96,951	90,745	80,415	93,406
EBIT	155,358	190,336	255,063	525,868	412,683	229,064
EBIT Margin	5.67%	6.97%	9.59%	16.76%	14.77%	10.65%
Effective Tax Rate	22.05%	22.02%	24.89%	22.09%	22.04%	16.87%

Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.